Healx raises $56 million to combat rare diseases with AI
October 16, 2019
Healx, a company that said it’s using artificial intelligence (AI) to discover new drug treatments for rare diseases, has raised $56 million in a series B round of funding led by Atomico, with participation from Intel Capital, Balderton Capital, Global Brain, Btov Partners, Amadeus Capital Partners, and Cambridge Innovation Capital’s Jonathan Milner.
Founded out of Cambridge in 2014, Healx’s…